BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03066778-completion@plaintrial.com
DTSTAMP:20261029T044912Z
DTSTART;VALUE=DATE:20210921
SUMMARY:A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Pl
 atinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Sm
 all Cell Lung Cancer (MK-3475-604/KEYNOTE-604) — estimated completion da
 te
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03066778
URL:https://plaintrial.com/trial/NCT03066778
END:VEVENT
END:VCALENDAR